Leonie de Best on Validation of EMC92/SKY92 Signature in Myeloma
May 4th 2016Leonie de Best, MSc2, chief operating officer, SkylineDX, discusses the HOVON-87/NMSG-18 study, which demonstrated the validation of the EMC92/SKY92 signature for elderly patients with newly diagnosed multiple myeloma.
Read More